0001600620-24-000036.txt : 20240307 0001600620-24-000036.hdr.sgml : 20240307 20240307164347 ACCESSION NUMBER: 0001600620-24-000036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240306 FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240307 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Donley Matthew Maxwell CENTRAL INDEX KEY: 0001636642 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36421 FILM NUMBER: 24730834 MAIL ADDRESS: STREET 1: 4520 EAST WEST HIGHWAY, 3RD FLOOR CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001600620 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981231763 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: #140, 14315 - 118 AVENUE CITY: EDMONTON STATE: A0 ZIP: T5L 4S6 BUSINESS PHONE: 250-744-2487 MAIL ADDRESS: STREET 1: #140, 14315 - 118 AVENUE CITY: EDMONTON STATE: A0 ZIP: T5L 4S6 4 1 wk-form4_1709847815.xml FORM 4 X0508 4 2024-03-06 0 0001600620 Aurinia Pharmaceuticals Inc. AUPH 0001636642 Donley Matthew Maxwell #140, 14315-118 AVENUE EDMONTON A0 T5L 4S6 ALBERTA, CANADA 0 1 0 0 EVP, Ops & Strategy 0 Common Stock 2024-03-06 4 S 0 40665 5.51 D 584072 D Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 2, 2022 and March 2, 2023 grants. The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.475 to $5.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Matthew Maxwell Donley 2024-03-07